New Markers Enter Uncharted Diagnostic Territory
As a patient, you want as much information about your health as possible, whether you have acute symptoms or feel perfectly healthy. Exciting developments are under way at Beckman Coulter in key areas including cardiac disease, prostate disease and high-risk pregnancy—tests that can change the course of disease management. The benefits are compelling, which is why Beckman Coulter has been collaborating with researchers, physicians and customers to pursue revolutionary new assays for promising biomarkers.
full story

Landmark Installation, Impressive Results
When the time came for the laboratory at Lake Forest Hospital in Lake Forest, Illinois (USA) to review the contract for its primary hematology system, the hospital made a landmark decision to install Beckman Coulter's newest hematology system—making it the first U.S. placement of the UniCel DxH 800 Coulter Cellular Analysis System. Read how this bold move led to lab-wide efficiencies—including a reduction in manual differentials by about 20 percent.
full story

Beckman Coulter: The Perfect Fit
When the Olympus Diagnostics acquisition was finalized, it significantly expanded Beckman Coulter's portfolio and solidified the company's position as the world's leading provider of chemistry analyzers and automation solutions. What does this new size and scope mean for Beckman Coulter customers? Take a look behind the scenes. full story

CAP Today Article Provides In-Depth Information on PSA Testing
Are you still confused about prostate-specific antigen (PSA) testing? If you want to better understand PSA standardization and learn about new markers on the horizon, check out the October issue of CAP Today. Published by The College of American Pathologists, the October issue features an in-depth article on PSA testing titled, "With PSA here to stay, how to manage its many ambiguities." Read what experts are saying about Hybritech-calibrated PSA assays and Beckman Coulter's latest PSA marker available now in Europe, plus current and future practices surrounding prostate cancer screening, risk stratification and treatment. Click here to read the CAP Today article.

Improved 2-Liter Clinical Reagent Bottles Coming Soon
In the past year, Beckman Coulter's 2-liter bottle for bulk clinical reagents has undergone a successful make-over providing customers with a more substantial container. And, most recently, Beckman Coulter gathered customer feedback to improve the dependability of the bottle's cap and its ability to prevent leakage. Read to learn more about the bottle's newest benefits. full story

New Online Publication: Rapid Diagnostics Quarterly
This month, Rapid Diagnostics Quarterly debuted online as Beckman Coulter's newest e-newsletter, specifically created to convey information about colorectal cancer (CRC) screening and rapid diagnostics testing. Read about the features included in the premier issue. full story

For more information on accessing data sheets, online training courses or maintenance & troubleshooting issues, visit Customer Support Center.